Elisabet Aliagas

L'hospitalet De Llobregat, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Single-cell RNA-sequencing as a potential approach for studying intratumor heterogeneity in pleural mesothelioma.

Single-cell RNA-sequencing as a potential approach for studying intratumor heterogeneity in pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2025

Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics.

Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics.

Journal: Cell death & disease
Published: April 24, 2025

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13.

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13.

Journal: Cells
Published: January 16, 2023

Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.

Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.

Journal: British journal of cancer
Published: April 18, 2021

Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification.

Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification.

Journal: Journal for immunotherapy of cancer
Published: January 19, 2021

Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients.

Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients.

Journal: Scientific reports
Published: October 24, 2018

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.

Journal: Respiratory research
Published: January 08, 2018

Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).

Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).

Journal: PloS one
Published: November 02, 2016

High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.

High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.

Journal: Mediators of inflammation
Published: November 19, 2013

Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis".

Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis".

Journal: Purinergic signalling
Published: May 08, 2013

Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium.

Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium.

Journal: Purinergic signalling
Published: September 26, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026